|
|
|
|
Drug Cures Osteoporosis in Mice
MONDAY, Feb.8 (HealthDay News) -- An experimental drug that inhibits serotonin in the gut cured osteoporosis in lab mice and rats, a new study has found. Previous research has shown that serotonin in the gut hinders bone formation. Most current...
|
|
|
Serotonin May Be a Key to Treat Osteoporosis
Study Shows Experimental Drug May Build New Bone by Decreasing Serotonin Levels in the Gut Feb.7, 2010 -- The hormone serotonin may hold the key to new treatments for reversing osteoporosis-related bone loss, new research finds. When investigators at...
|
|
|
Inhibiting Serotonin In Gut Could Cure Osteoporosis
An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb.7...
|
|
|
Drug Found to Inhibit, Reverse Osteoporosis in Rodents
MONDAY, Feb.8 (HealthDay News) -- An investigational drug that blocks the synthesis of serotonin in the gut prevents and reverses osteoporosis in a rodent model of the disease by promoting bone formation, according to a study published online Feb. 7...
|
|
|
Working Life: Olivier Leupin
After receiving a masters degree in biology at the University of Lausanne, I travelled a long way down Lake Geneva to complete a Ph.D.program at the University of Geneva in the department of microbiology and molecular medicine. My research focused on the...
|
|
|
Osteoporosis Could be Cured by Inhibiting Serotonin in Gut
An international team led by researchers from Columbia University Medical Center says that an investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats.The study...
|
|
|
Building Bones Complementary Approach in Osteoporosis Fight
In the Feb.7, 2010, online edition of Nature Medicine, scientists described an anabolic approach to increasing bone mass: In rodents, they were able to increase osteoblast activity and, ultimately, bone mass and function, by inhibiting gut serotonin. Bone...
|
|
|
Medical News: Inhibiting Serotonin In Gut Could Cure Osteoporosis
An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb.7...
|
|
|
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.(AP) -- Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.The drug, also called Prolia, is viewed by Wall Street...
|
|
|
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.(AP) -- Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.The drug, also called Prolia, is viewed by Wall Street...
|
|
|
Low level nicotine: A novel approach to reduce osteoporosis incidence
Zhang J et al.Here, the authors review the clinical evidence on nicotine consumption and osteoporosis, and propose a possible protective mechanism. It should be note that there is no strong clinical evidence that proves nicotine is detrimental.
|
|
|
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.(AP) ' Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study. The drug, also called Prolia, is viewed by Wall...
|
|
|
Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats
_ Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats.
|
|
|
Amgen Sees Positive Data In Bone Drug Study
THOUSAND OAKS, Calif.-- Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study. The drug, also called Prolia, is viewed by Wall Street as...
|
|
|
New osteoporosis treatment available in the UK
Magnetic Resonance Therapy, or MBST, uses low-power magnetic resonance signals to stimulate the regeneration of damaged cartilage and bone cells.Axel Muntermann, managing director of the German company who developed the treatment, said: 'With an aging...
|
|
|
Amgen Advances Effort To Sell Bone Drug For Cancer Patients
NEW YORK -(Dow Jones)- The third success of Amgen Inc.'s (AMGN) experimental bone drug denosumab in helping prevent bone complications in cancer patients increases the drug's chances of regulatory approval, even as the biotech awaits to bring the same drug to...
|
|
|
Amgen Advances Effort To Sell Bone Drug For Cancer Patients
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- The third success of Amgen Inc.'s (AMGN) experimental bone drug denosumab in helping prevent bone complications in cancer patients increases the drug's chances of regulatory approval, even as the...
|
|
|
Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats
_ Daily Serotonin Production Blocker Helped Treat Osteoporosis in Mice, Rats.
|
|
|
Beer for Better Bones?
Beer Is a Rich Source of Bone-Boosting Silicon, Study Finds WebMD Health News Feb.8, 2010 -- Drinking beer may be good for building more than just beer bellies. A new study suggests that drinking beer may help build better bones thanks to its high silicon...
|
|
|
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.- Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study. The drug, also called Prolia, is viewed by Wall Street as...
|
|
|
Bone Up On This Potential Blockbuster
Investors patiently waiting for the Food and Drug Administration to approve Amgen's (Nasdaq: AMGN) bone drug Prolia may finally be seeing the light at the end of the tunnel.Yesterday Amgen released positive results from its third phase 3 trial pitting Prolia...
|
|
|
Bone Up On This Potential Blockbuster
Investors patiently waiting for the Food and Drug Administration to approve Amgen's (Nasdaq: AMGN) bone drug Prolia may finally be seeing the light at the end of the tunnel.Yesterday Amgen released positive results from its third phase 3 trial pitting Prolia...
|
|
|
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study. The drug, also called Prolia, is viewed by Wall Street as...
|
|
|
Amgen sees positive data in bone drug study
THOUSAND OAKS, Calif.Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study. The drug, also called Prolia, is viewed by Wall Street as...
|
|
|
Amgen Sees Positive Data In Bone Drug Study
THOUSAND OAKS, Calif.(AP) - Amgen Inc. said its osteoporosis drug candidate denosumab beat a rival drug in reducing and delaying the rate of fractures in men with prostate cancer during a study.The drug, also called Prolia, is viewed by Wall Street...
|
